PET works by injecting a biologically active molecule labeled with a positron-emitting isotope into the body. The most commonly used tracer is Fluorodeoxyglucose (FDG), a glucose analog. Once in the body, the tracer accumulates in tissues with high metabolic activity, such as cancer cells, which can then be detected by the PET scanner. The scanner captures the gamma rays and reconstructs them into detailed images.
